CJC-1295 with DAC
Also known as CJC-1295 DAC · Drug Affinity Complex CJC · CJC with DAC
New
Reconstitution & dosing guide
2 mg · 5 mg vial sizes — research phases, recon steps, and a live unit calculator.
Available sizes & price
Catalog only2mg x 10 vials
CJC1295 with DAC (CD2) · Not in current stock
$25 / vial
5mg x 10 vials
CJC1295 with DAC (CD5) · Not in current stock
$40 / vial
Prices per vial · Research use only · Not medical advice.
Long-acting GHRH analogue form of CJC-1295 using Drug Affinity Complex for multi-day GH/IGF-1 elevation research framing.
How to picture it
A research compound with pathways still being mapped — see mechanism and overview for the technical picture.
Research focus & benefits
- Extended GH secretagogue PK models
- Body composition research contexts
- Comparison vs no-DAC Mod GRF 1-29
Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.
Overview
CJC-1295 with DAC binds albumin via the Drug Affinity Complex, extending half-life versus Mod GRF 1-29 (no DAC). Research-market use is typically once or twice weekly. Many biohackers prefer the no-DAC form for more physiologic pulses; DAC remains stocked as a distinct vial SKU.
Mechanism
GHRH receptor agonism on pituitary somatotrophs with prolonged exposure from albumin binding, producing flatter multi-day GH/IGF-1 elevation than short pulses.
Research uses
- Extended GH secretagogue PK models
- Body composition research contexts
- Comparison vs no-DAC Mod GRF 1-29
Research dosing notes
Educational community ranges often ~0.5–2 mg once or twice weekly. Distinct from daily no-DAC pulse dosing.
Half-life / kinetics
Multi-day (DAC / albumin extension)
Common research routes
Reported considerations
- Water retention
- Tingling / numbness
- IGF-1 elevation concerns
- Less physiologic GH pattern than pulse stacks
Contraindications / cautions
- Active cancer
- Uncontrolled diabetes
- Pregnancy
Common research stacks
- Ipamorelin (less common with DAC)
- Tesamorelin
- BPC-157
Legal / access note
Not FDA-approved. Research powders are not pharmaceutical product.